Chi Onwurah, chair of the science, innovation and technology select committee, has dismissed Palantir's claim that opposition to their £330m NHS contract stems from ideological bias. She also affirmed the government's right to explore ways to exit the contract with the US data firm.
A new wave of startups in the Northeast is harnessing AI technology to enhance patient monitoring, streamline case reviews, and speed up clinical decision-making processes.
The Trump administration is reverting the federal health IT office's name to the Office of the National Coordinator, signaling a shift in its responsibilities and oversight.
Louis Mosley, Palantir's UK head, has called on the government to resist pressure from ideologically driven groups as ministers consider activating a break clause in the company's £330 million contract with the NHS. The deal involves delivering the Federated Data Platform (FDP), a core data infrastructure for the NHS. Concerns about Palantir's involvement in public sector projects have led to government reviews and fresh scrutiny.
Mantis Biotech integrates diverse data sources to create synthetic datasets that simulate 'digital twins' of the human body. These models capture anatomy, physiology, and behavior, providing a comprehensive digital representation to improve medical research and development.
Leading for-profit health insurance companies are experiencing a slowdown in job creation, with major insurers reducing their workforce. Additionally, upcoming Medicaid budget cuts threaten to compel hospitals to reduce staff numbers, signaling broader employment challenges in the healthcare sector.
London-based JAAQ, a digital health engagement platform covering 1.5 million eligible users, has raised $17 million in a Series A round. The funding will support the company's expansion into the US market and strengthen its clinical framework, led by a new CEO with a proven track record including a successful exit to Adobe.
Oni Blackstock argues that the integration of AI in healthcare should prioritize earning the trust of patients and providers over rapid financial investment. The development and deployment of AI technologies must move cautiously and transparently to avoid exacerbating the existing trust issues within medicine.
The healthcare crisis in the U.S. is driven by escalating costs, coverage shortfalls, overwhelming medical debt, and restricted access. While nonprofits and companies are implementing creative solutions, experts warn the crisis will worsen without significant federal policy reform. Nonprofits like Undue Medical Debt have relieved $27 billion of medical debt for millions by buying debt at a fraction of its value, yet the growing debt burden remains concerning. State-level protections offer some relief but are only stopgap measures. Federal policy cuts, such as a $1 trillion reduction in Medicaid funding over the next decade, threaten to increase overall healthcare expenses, impacting employers and employees alike. Companies like Lantern are helping reduce specialty care costs by guiding members toward affordable, high-quality options. Legal advocacy also plays a critical role; the ACLU has successfully challenged policies in the courts, emphasizing the power of collective voices in pushing for change. Business leaders are urged to advocate actively to safeguard and improve the healthcare system.
Healthcare marketing carries high stakes, now amplified by AI's growing role. With 70% of healthcare organizations leveraging AI in 2026, it's transforming operations like content creation, patient engagement, and personalized marketing. This guide explores effective AI-driven marketing strategies, key tools, compliance challenges, and inspiring examples from leading health systems. Learn how AI enhances targeting, predictive analytics, voice agent use, and ensures ROI while navigating HIPAA and FDA regulations. Discover how healthcare marketers can responsibly harness AI to build trust, improve patient acquisition, and streamline campaigns in a complex, regulated environment.
